Madison Weatherly
Overview
Explore the profile of Madison Weatherly including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
163
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang Y, Bousvaros A, Docktor M, Kaplan A, Rufo P, Leier M, et al.
Sci Rep
. 2024 Aug;
14(1):18188.
PMID: 39107366
Fecal Microbiota Transplant (FMT) has shown some success in treating inflammatory bowel diseases (IBD). There is emerging evidence that host engraftment of donor taxa is a tenet of successful FMT....
2.
Rodig N, Weatherly M, Kaplan A, Ballal S, Elisofon S, Daly K, et al.
Transplantation
. 2023 May;
107(9):2073-2077.
PMID: 37211643
Background: Fecal microbiota transplant (FMT) is an effective treatment for recurrent Clostridioides difficile infection (CDI). Safety concerns around FMT are increased in immunocompromised populations, such as solid organ transplant (SOT)...
3.
Zhang Y, Bousvaros A, Docktor M, Kaplan A, Rufo P, Leier M, et al.
medRxiv
. 2023 Feb;
PMID: 36778473
Background: Fecal Microbiota Transplant (FMT) has proven effective in treating recurrent infection (rCDI) and has shown some success in treating inflammatory bowel diseases (IBD). There is emerging evidence that host...
4.
Conover K, Absah I, Ballal S, Brumbaugh D, Cho S, Cardenas M, et al.
J Pediatr Gastroenterol Nutr
. 2023 Jan;
76(4):440-446.
PMID: 36720105
Objectives: We sought to evaluate the safety and effectiveness of fecal microbiota transplantation (FMT) for recurrent Clostridioides difficile infection (CDI) in pediatric immunocompromised (IC) patients. Methods: This is a multicenter...
5.
Edwards P, Thurm C, Hall M, Busing J, Kahn S, Kellermayer R, et al.
J Pediatr
. 2022 Aug;
252:111-116.e1.
PMID: 36027981
Objectives: To compare the incidence, epidemiology, testing patterns, treatment, and outcomes of Clostridioides difficile infection (CDI) among hospitalized pediatric patients from 2013 to 2019. Study Design: The Pediatric Health Information...
6.
Nicholson M, Alexander E, Ballal S, Davidovics Z, Docktor M, Dole M, et al.
J Crohns Colitis
. 2021 Nov;
16(5):768-777.
PMID: 34788420
Background: Children with inflammatory bowel disease [IBD] are disproportionally affected by recurrent Clostridioides difficile infection [rCDI]. Although faecal microbiota transplantation [FMT] has been used with good efficacy in adults with...
7.
Nicholson M, Hourigan S, Conrad M, Goyal A, Jensen K, Kelsen J, et al.
Am J Gastroenterol
. 2021 Jun;
116(9):1954-1956.
PMID: 34140459
Introduction: The impact of the 2019 US Food and Drug Administration safety alert involving transmission of multidrug resistant organisms through fecal microbiota transplantation (FMT), and the COVID-19 pandemic on the...
8.
Panou V, Gadiraju M, Wolin A, Weipert C, Skarda E, Husain A, et al.
J Clin Oncol
. 2018 Aug;
36(28):2863-2871.
PMID: 30113886
Purpose: The aim of the current study was to determine the prevalence and clinical predictors of germline cancer susceptibility mutations in patients with malignant mesothelioma (MM). Methods: We performed targeted...
9.
Vasanthakumar A, Arnovitz S, Marquez R, Lepore J, Rafidi G, Asom A, et al.
Blood
. 2015 Dec;
127(3):310-3.
PMID: 26644450
BRCA1 is critical for maintenance of genomic stability and interacts directly with several proteins that regulate hematopoietic stem cell function and are part of the Fanconi anemia (FA) double-strand break...